"Neurotoxicity Syndromes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.
| Descriptor ID |
D020258
|
| MeSH Number(s) |
C10.720 C25.723.705
|
| Concept/Terms |
Neurotoxicity Syndromes- Neurotoxicity Syndromes
- Neurotoxicity Syndrome
- Syndrome, Neurotoxicity
- Syndromes, Neurotoxicity
- Neurotoxin Disorders
- Neurotoxin Disorder
- Neurotoxic Disorders
- Neurotoxic Disorder
- Neurotoxin Diseases
- Neurotoxin Disease
- Poisoning, Nervous System
- Nervous System Poisonings
- Poisonings, Nervous System
- Nervous System Poisoning
Encephalopathy, Toxic- Encephalopathy, Toxic
- Encephalopathies, Toxic
- Toxic Encephalopathies
- Toxic Encephalopathy
Toxic Encephalitis- Toxic Encephalitis
- Encephalitides, Toxic
- Encephalitis, Toxic
- Toxic Encephalitides
|
Below are MeSH descriptors whose meaning is more general than "Neurotoxicity Syndromes".
Below are MeSH descriptors whose meaning is more specific than "Neurotoxicity Syndromes".
This graph shows the total number of publications written about "Neurotoxicity Syndromes" by people in this website by year, and whether "Neurotoxicity Syndromes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 11 | 1 | 12 |
| 2018 | 13 | 5 | 18 |
| 2019 | 7 | 2 | 9 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neurotoxicity Syndromes" by people in Profiles.
-
Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clin Cancer Inform. 2021 06; 5:668-678.
-
A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021 01 26; 96(4):e575-e586.
-
Covid-19 treatment-induced neuropsychiatric adverse effects. Gen Hosp Psychiatry. 2020 Nov - Dec; 67:163-164.
-
Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation. Psychosomatics. 2020 Nov-Dec; 61(6):859-860.
-
Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database. Biosci Trends. 2020 May 21; 14(2):139-143.
-
Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020 07; 87:18-22.
-
Pivotal role of cAMP-PKA-CREB signaling pathway in manganese-induced neurotoxicity in PC12 cells. Environ Toxicol. 2019 Sep; 34(9):1052-1062.
-
Neurotoxic effects of mercury exposure in dental personnel. Basic Clin Pharmacol Toxicol. 2019 May; 124(5):568-574.
-
Plant components can reduce methylmercury toxication: A mini-review. Biochim Biophys Acta Gen Subj. 2019 12; 1863(12):129290.
-
Garbled speech: a rare presentation of metronidazole-induced neurotoxicity. BMJ Case Rep. 2019 Mar 01; 12(3).